High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies

J Clin Microbiol. 2020 Oct 21;58(11):e01352-20. doi: 10.1128/JCM.01352-20. Print 2020 Oct 21.

Narjis Boukli¹, Melchior Le Mene^#², Aurélie Schnuriger^#^{3

4

5}, Nancy Stella Cuervo², Cécilia Laroche², Laurence Morand-Joubert^{2

4

6}, Joël Gozlan^{2

4

7}

¹ AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France [email protected].
² AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France.
³ AP-HP, Centre Hospitalo-Universitaire Trousseau, Laboratoire de Virologie, Paris, France.
⁴ Sorbonne Universités, Paris, France.
⁵ INSERM, UMR_S 938, Centre de Recherche Saint-Antoine Metabolic and Biliary, Fibro-inflammatory Diseases of the Liver, Paris, France.
⁶ INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.
⁷ INSERM, UMR_S 938, Centre de Recherche Saint-Antoine Cancer Biology and Therapeutics, Paris, France.

^# Contributed equally.

No abstract available

Keywords: COVID-19; SARS-CoV-2; antibodies; coronavirus; serological tests.

Publication types